{"text_format":"3","workbook":"xls","n_sheets":2,"sheets":["z.score","adj.p"],"not_rendered":{"external_links":1},"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"z.score","index":0,"n_rows":175,"n_cols":8,"rows_kept":175,"flags":["formulas_cached_only"]}
["Canonical Pathways","Bulk_1G_Q_vs_1G","Bulk_uG_vs_1G","Bulk_uG_Q_vs_1G","Bulk_uG_Q_vs_uG","GLDS-420_host_counts_DEG","SC_uGvs1G_unstimulated","SC_uGvs1G_stimulated"]
["Phagosome Formation",-7.517,-3.528,-8.798,-6.799,1.043,1.342,1.069]
["Pathogen Induced Cytokine Storm Signaling Pathway",-8.12,-3.182,-7.775,-6.139,"N/A",0.354,"N/A"]
["Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes",7.894,0.378,7.485,7.484,"N/A",-1,0.447]
["Neuroinflammation Signaling Pathway",-6.601,-1.604,-6.736,-6.263,"N/A",1.225,1.528]
["T Cell Receptor Signaling",6.405,0.302,6.041,6.172,"N/A",-2.837,-0.832]
["CTLA4 Signaling in Cytotoxic T Lymphocytes",-6.985,-0.535,-6.635,-6.935,"N/A",1.225,"N/A"]
["Dendritic Cell Maturation",-5.735,-2,-6.04,-5.277,-0.378,-1.147,1]
["Role of Hypercytokinemia/hyperchemokinemia in the Pathogenesis of Influenza",-5.396,-1.667,-5.048,-4.7,-2,1.134,0.277]
["Role Of Osteoclasts In Rheumatoid Arthritis Signaling Pathway",-5.194,-2.84,-5,-4.445,"N/A",2.53,"N/A"]
["CREB Signaling in Neurons",-4.028,-3.266,-4.964,-3.382,1.633,1,0.816]
["IL-8 Signaling",-3.442,-1.667,-4.007,-4.093,"N/A",3.162,2.714]
["Multiple Sclerosis Signaling Pathway",-5.481,-3,-5.618,-3.579,"N/A",-1.043,"N/A"]
["Necroptosis Signaling Pathway",-3.429,-2.236,-4.423,-3.162,2,1.667,-1.508]
["TREM1 Signaling",-5.06,-0.378,-5.516,-4.867,"N/A",0.707,1.89]
["G-Protein Coupled Receptor Signaling",-4.814,-2.746,-4.975,-3.571,0.626,1.155,0.333]
["Production of Nitric Oxide and Reactive Oxygen Species in Macrophages",-3.91,-2.309,-3.677,-3.046,-1,1.941,2.324]
["Macrophage Classical Activation Signaling Pathway",-4.924,-3.128,-4.75,-3.615,"N/A",0.2,"N/A"]
["Interferon Signaling",-3.5,-1.134,-3.357,-3.5,-2.236,-0.707,-2.111]
["Coronavirus Pathogenesis Pathway",-2.324,2.333,-3.349,-4.093,0.707,0.626,2.837]
["Colorectal Cancer Metastasis Signaling",-4.478,-1.387,-4.65,-4.478,"N/A",0.816,0.378]
["Tumor Microenvironment Pathway",-3.311,-1.732,-3.677,-3.151,0.447,1.155,1.807]
["EIF2 Signaling",3.429,"N/A",3.91,4.557,"N/A",0.408,-2.84]
["Signaling by Rho Family GTPases",-3.615,-0.816,-4.158,-2.668,1.342,-0.302,1.897]
["Role of NFAT in Regulation of the Immune Response",-2.668,-2.333,-3.25,-3.108,"N/A",-2.183,1]
["Pyroptosis Signaling Pathway",-3.452,-1.667,-3.452,-2.271,"N/A",-1.89,-1.633]
["Toll-like Receptor Signaling",-3.8,"N/A",-3.674,-3.411,"N/A",2,1.342]
["Acute Phase Response Signaling",-3.124,0,-3.395,-3.795,0.816,1.414,1.667]
["Synaptogenesis Signaling Pathway",-2.041,-3.051,-3.215,-2.063,1.667,0.707,1.414]
["Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes",-3.317,-1.342,-3.753,-3.647,"N/A",0,2]
["IL-6 Signaling",-2.785,1,-3.43,-3.656,"N/A",1.342,1.508]
["Breast Cancer Regulation by Stathmin1",-3.546,-2.4,-4.177,-2.506,0,0.378,0.302]
["IL-17 Signaling",-2.949,-1.897,-3.175,-1.342,-1,1.155,1.732]
["HMGB1 Signaling",-3,-0.333,-3.363,-2.466,"N/A",1.89,2.121]
["Hepatic Fibrosis Signaling Pathway",-2.435,-0.229,-2.946,-2.203,1.886,1.414,2.041]
["Integrin Signaling",-3.16,-0.378,-3.255,-2.357,1.633,0.707,1.633]
["Role Of Chondrocytes In Rheumatoid Arthritis Signaling Pathway",-4.533,-0.447,-4.355,-3.539,"N/A",0,"N/A"]
["iNOS Signaling",-4,"N/A",-3.638,-3.5,"N/A",1.134,0.447]
["Antioxidant Action of Vitamin C",3.286,1,3.922,4.041,"N/A",-0.447,"N/A"]
["Adrenomedullin signaling pathway",-2.774,-0.816,-3.394,-3.286,1,"N/A",1.342]
["Pulmonary Healing Signaling Pathway",-2.194,-0.333,-2.982,-3.064,1.897,1,1.134]
["Role of PKR in Interferon Induction and Antiviral Response",-2.197,-1.134,-2.722,-1.947,"N/A",-1.941,-2.496]
["Cardiac Hypertrophy Signaling",-2.945,-2.111,-3.15,-1.987,"N/A",0.378,1.633]
["PI3K Signaling in B Lymphocytes",-2.287,-1.342,-2.771,-3.317,"N/A",1.342,1.134]
["Oxytocin Signaling Pathway",-2.68,-1.265,-3.25,-2.157,1.633,0,1.134]
["Chemokine Signaling",-3.087,"N/A",-3.452,-3.773,"N/A",0.447,1.134]
["Endothelin-1 Signaling",-2.646,-0.447,-3.098,-3.311,2.121,0,0]
["Synaptic Long Term Depression",-2.1,-1.89,-2.263,-1.857,2.449,1,"N/A"]
["Regulation of Actin-based Motility by Rho",-2.694,0,-3.053,-3.053,"N/A",1.342,1.342]
["Differential Regulation of Cytokine Production in Intestinal Epithelial Cells by IL-17A and IL-17F",-2.828,"N/A",-2.828,-2.828,"N/A",1.342,1.633]
["PPAR Signaling",1.961,"N/A",3.157,2.921,"N/A",-2.236,-1.134]
["Senescence Pathway",-1.806,1.134,-2.151,-2.077,2.236,-1,-1]
["Xenobiotic Metabolism AHR Signaling Pathway",-3.286,0,-2.828,-3.4,"N/A",-1,-0.816]
["Sirtuin Signaling Pathway",-0.866,2,-0.457,-1.26,1,2.714,3]
["Systemic Lupus Erythematosus In B Cell Signaling Pathway",-2.132,-2.837,-2.513,-1.2,-0.816,-0.775,-0.894]
["RHOA Signaling",-2.535,"N/A",-3.55,-2.667,"N/A",-1.134,1]
["Estrogen Receptor Signaling",-2.014,-1.732,-2.53,-1.627,1.89,0.707,-0.378]
["Immunogenic Cell Death Signaling Pathway",-3.413,0,-2.828,-2.197,"N/A",2.324,"N/A"]
["Unfolded protein response",-2.357,"N/A",-2.183,-3.441,"N/A",2.449,"N/A"]
["FAK Signaling",1.976,-2.611,1.313,2.815,0.756,0.688,-0.243]
["Differential Regulation of Cytokine Production in Macrophages and T Helper Cells by IL-17A and IL-17F",-2.449,"N/A",-2.449,-2.449,"N/A",1.342,1.633]
["Cardiac Hypertrophy Signaling (Enhanced)",-2.073,-3,-2.359,-1.247,0.728,-0.258,0.577]
["RHOGDI Signaling",2.343,1.134,3.395,2.359,"N/A",0,-1]
["Reelin Signaling in Neurons",-1.761,-1.342,-1.718,-1.64,2,0,1.633]
["Osteoarthritis Pathway",-2.06,-1,-2.449,-1.98,0.447,-0.707,1.342]
["Gαq Signaling",-2.412,-0.707,-2.03,-2.655,"N/A","N/A",2]
["Leukocyte Extravasation Signaling",-2.25,0,-2.462,-2.142,0.816,0.707,1.414]
["Role of NFAT in Cardiac Hypertrophy",-2.474,-1.89,-2.433,-2.06,"N/A",-0.816,"N/A"]
["Sperm Motility",-1.48,-1.342,-2.058,-2.556,2.236,"N/A","N/A"]
["CXCR4 Signaling",-1.98,-0.378,-2.496,-2.111,"N/A",1.342,1.342]
["LXR/RXR Activation",1.372,-1.342,1.219,1.219,-1.342,-1.414,-1.667]
["Insulin Secretion Signaling Pathway",-1.89,-2.714,-2.286,-1.336,"N/A",-0.632,-0.707]
["fMLP Signaling in Neutrophils",-1.581,"N/A",-1.718,-2.722,"N/A",1.633,1.89]
["Nitric Oxide Signaling in the Cardiovascular System",-1.512,"N/A",-1.512,-1.46,2,1,2]
["Actin Cytoskeleton Signaling",-1.664,"N/A",-2.646,-1.89,0.816,-0.333,2]
["IL-15 Production",-0.632,-2.449,-1.761,-0.649,2.53,-1.265,0]
["Activation of IRF by Cytosolic Pattern Recognition Receptors",-1.807,-2,-1.606,-1.606,"N/A","N/A",-2.236]
["Th1 Pathway",-2.38,-0.632,-2.449,-2.38,"N/A",-1.069,0.302]
["PKCθ Signaling in T Lymphocytes",-1.414,-2.236,-1.753,-1.483,"N/A",-1.604,0.707]
["IL-13 Signaling Pathway",-2.333,0,-2.795,-2.191,"N/A",-1.134,0.707]
["Pulmonary Fibrosis Idiopathic Signaling Pathway",-1.818,-0.728,-2.266,-1.726,1.604,0,1]
["NF-κB Signaling",-1.549,"N/A",-1.386,-1.638,2.333,-1.414,0.816]
["T Cell Exhaustion Signaling Pathway",-1.543,-3,-1.372,-1.809,"N/A",-0.378,-1]
["RAC Signaling",-1.677,"N/A",-2.714,-2.188,"N/A",0.816,1.633]
["Opioid Signaling Pathway",-1.565,-1,-1.325,-1.606,1.89,0.707,0.816]
["CDC42 Signaling",-1.859,"N/A",-3.124,-2.667,"N/A",-0.707,0.447]
["Ephrin Receptor Signaling",-1.871,-1,-2.138,-1.692,1.633,0,0.447]
["NAD Signaling Pathway",-2.887,0.302,-1.938,-2.48,"N/A",1,0]
["Natural Killer Cell Signaling",-1.94,-1.89,-2.018,-0.688,1.633,-0.426,0]
["Oxidative Phosphorylation",-2.673,"N/A",-2.496,-2.111,"N/A",-1.069,"N/A"]
["Role of MAPK Signaling in Inhibiting the Pathogenesis of Influenza",-2.449,"N/A",-2.6,-2.558,"N/A",0.378,0.333]
["Cholecystokinin/Gastrin-mediated Signaling",-2.03,0,-2.412,-2.402,"N/A",0,1.342]
["HOTAIR Regulatory Pathway",-2.271,0,-2.333,-2.343,0,0,1.134]
["Autophagy",-2.142,"N/A",-1.778,-2.994,0.447,"N/A",0.707]
["Regulation Of The Epithelial Mesenchymal Transition By Growth Factors Pathway",-1.214,-2.236,-1.604,-1.089,1.134,-0.447,-0.333]
["GP6 Signaling Pathway",-1.298,"N/A",-1.859,-1.715,1.134,0,2]
["Role of IL-17F in Allergic Inflammatory Airway Diseases",-1.667,"N/A",-1.155,-1.265,"N/A",2,1.89]
["Ferroptosis Signaling Pathway",-1.234,-1.89,-1.697,-1.443,1,-0.333,-0.333]
["Inhibition of ARE-Mediated mRNA Degradation Pathway",-2.646,-1.342,-2.556,-0.928,"N/A",-0.447,0]
["ICOS-ICOSL Signaling in T Helper Cells",-0.973,-2,-1.333,-1,"N/A",-1.265,1.342]
["p38 MAPK Signaling",-2.921,"N/A",-2.744,-1.89,"N/A",0,-0.333]
["TEC Kinase Signaling",-1.604,-1.134,-2.023,-1.786,"N/A",-0.577,0.632]
["HIF1α Signaling",-1.638,-0.447,-1.861,-1.698,0.333,0.302,1.387]
["MSP-RON Signaling In Macrophages Pathway",1.809,0.447,0.98,2.1,"N/A",0.632,-1.667]
["PI3K/AKT Signaling",-1.616,"N/A",-2.335,-2.744,"N/A",0.816,"N/A"]
["Wound Healing Signaling Pathway",-2.142,-1.604,-2.708,-0.728,0,-0.277,0]
["Thrombin Signaling",-1.26,-1,-2.1,-1.938,"N/A","N/A",1]
["Retinoic acid Mediated Apoptosis Signaling",-1.291,-1,-1.387,-1.604,"N/A","N/A",-2]
["14-3-3-mediated Signaling",-1.715,"N/A",-2.333,-2.197,1,"N/A","N/A"]
["Systemic Lupus Erythematosus In T Cell Signaling Pathway",-1.709,-1.155,-1.585,-1.688,"N/A",-0.577,0.5]
["Dopamine-DARPP32 Feedback in cAMP Signaling",-1.093,-2.121,-1.298,-1.667,1,"N/A","N/A"]
["BAG2 Signaling Pathway",-0.632,"N/A",0.258,-0.302,1,2.828,2]
["CD28 Signaling in T Helper Cells",-1.298,"N/A",-1.761,-2.03,"N/A",-1.342,0.447]
["Type I Diabetes Mellitus Signaling",-1.877,0.447,-1.569,-1.8,"N/A",-0.832,-0.302]
["cAMP-mediated signaling",-1.408,-2.333,-1.016,-0.397,1.667,0,"N/A"]
["Oxytocin In Brain Signaling Pathway",-1.231,-2.236,-1.1,-0.868,"N/A",-0.816,0.447]
["Erythropoietin Signaling Pathway",1.474,0.302,0.849,0.143,-1.633,-1,-1.265]
["NRF2-mediated Oxidative Stress Response",-0.756,"N/A",-0.343,-1.826,"N/A",1.89,1.633]
["Apelin Adipocyte Signaling Pathway",-1.8,"N/A",-1.8,-1.528,"N/A",-0.447,-0.816]
["ID1 Signaling Pathway",-0.62,-2,-1.083,-0.254,1,-0.707,0.707]
["Cytotoxic T Lymphocyte-mediated Apoptosis of Target Cells",0.707,"N/A",1,1.265,"N/A",-1.633,-1.633]
["Death Receptor Signaling",-0.186,0,-0.378,-0.784,"N/A",-2.236,-2.646]
["EGF Signaling",-1.604,"N/A",-2,-1.604,"N/A","N/A",-1]
["ERK/MAPK Signaling",-0.944,-0.447,-0.788,-0.662,2.449,0,-0.816]
["GM-CSF Signaling",-1.606,"N/A",-2.132,-1.789,"N/A",0,0.447]
["STAT3 Pathway",-1.151,0.447,-1.406,-0.973,1.897,0,"N/A"]
["Prolactin Signaling",0.192,-1,-0.539,-0.962,"N/A",-2,-0.816]
["Factors Promoting Cardiogenesis in Vertebrates",-0.457,-1.265,-0.632,-0.973,2,"N/A","N/A"]
["eNOS Signaling",-0.756,"N/A",-1.461,-1.095,0,-2,"N/A"]
["PD-1, PD-L1 cancer immunotherapy pathway",0,1.633,0.667,0.169,"N/A",2.065,0.632]
["Kinetochore Metaphase Signaling Pathway",1.155,"N/A",0,0.832,-3.162,"N/A","N/A"]
["CD40 Signaling",-1.069,"N/A",-1.5,-1.5,"N/A","N/A",-1]
["Telomerase Signaling",-0.853,"N/A",-1.279,-0.447,"N/A",1.342,1]
["CCR5 Signaling in Macrophages",-1.291,"N/A",-1.5,-1.604,"N/A","N/A",-0.447]
["Aryl Hydrocarbon Receptor Signaling",-0.577,-0.816,-0.557,-0.73,-1,-1.134,0]
["OX40 Signaling Pathway",1.265,"N/A",0.577,0.577,"N/A",-1.342,-1]
["Inhibition of Angiogenesis by TSP1",-1.134,"N/A",-1.414,-1.134,"N/A",-1,"N/A"]
["ILK Signaling",-0.816,-0.816,-1.214,-0.412,1.342,0,0]
["Ephrin B Signaling",-1.043,"N/A",-1.347,-1.177,1,"N/A","N/A"]
["NUR77 Signaling in T Lymphocytes",0.816,-1,0.626,0.655,"N/A",-1,-0.447]
["Glioma Invasiveness Signaling",-0.577,0,-1.257,-1.347,"N/A","N/A",1.342]
["Sphingosine-1-phosphate Signaling",-0.973,-0.378,-1.48,-0.686,1,"N/A","N/A"]
["CLEAR Signaling Pathway",-0.381,0.632,-0.095,-0.1,-2.121,"N/A",1]
["Thrombopoietin Signaling",-0.626,"N/A",-1.4,-1.225,"N/A","N/A",-1]
["Huntington's Disease Signaling",-0.324,-0.447,-1.067,-0.354,"N/A",2,"N/A"]
["PEDF Signaling",-0.853,"N/A",-1.177,-0.816,"N/A","N/A",-1.342]
["JAK/STAT Signaling",-0.408,0,-1.3,-1.569,"N/A","N/A",-0.816]
["Granzyme A Signaling",0.832,"N/A",0.302,0.832,"N/A",2.121,"N/A"]
["Apelin Endothelial Signaling Pathway",-0.667,"N/A",-1.298,-1.461,"N/A","N/A",0.447]
["Calcium-induced T Lymphocyte Apoptosis",-0.557,"N/A",-0.577,-0.378,"N/A",-1.897,0.447]
["Corticotropin Releasing Hormone Signaling",-0.686,0,-0.48,-0.686,2,"N/A","N/A"]
["BEX2 Signaling Pathway",-0.471,"N/A",-1.091,-0.894,"N/A","N/A",-1.342]
["Induction of Apoptosis by HIV1",0.277,"N/A",0.728,0.258,"N/A",-2.449,"N/A"]
["PTEN Signaling",-0.169,"N/A",0.522,0.354,-2.53,"N/A","N/A"]
["IL-7 Signaling Pathway",-0.209,-1,-0.853,0,"N/A",0,1.342]
["FAT10 Cancer Signaling Pathway",-0.535,"N/A",-0.535,-1.155,"N/A",-1,"N/A"]
["IL-23 Signaling Pathway",0.277,"N/A",0.535,0.258,"N/A",-1,-1.134]
["Th2 Pathway",-0.277,0,-1.214,-0.438,"N/A",-1.265,0]
["CDX Gastrointestinal Cancer Signaling Pathway",-0.687,1.069,-0.272,-0.832,"N/A",0.333,"N/A"]
["Endocannabinoid Cancer Inhibition Pathway",0.617,"N/A",0.152,0.48,0.816,"N/A",-1]
["Inhibition of Matrix Metalloproteases",1,"N/A",1,1,"N/A","N/A","N/A"]
["Role of IL-17A in Psoriasis",-1,"N/A",0,"N/A","N/A","N/A",2]
["Protein Kinase A Signaling",0.329,0.333,0.663,-0.115,1.155,0.333,"N/A"]
["HER-2 Signaling in Breast Cancer",-0.397,"N/A",-0.516,-0.911,-0.447,0.277,0.333]
["Sumoylation Pathway",0,"N/A",-0.426,-0.218,"N/A","N/A",-2.236]
["PPARα/RXRα Activation",0,"N/A",0.457,0.801,"N/A",-1.134,-0.447]
["Tumoricidal Function of Hepatic Natural Killer Cells",-0.447,"N/A",0,0.378,"N/A","N/A",-2]
["Semaphorin Neuronal Repulsive Signaling Pathway",-0.412,"N/A",-1,-0.289,0.378,-0.447,"N/A"]
["Neuroprotective Role of THOP1 in Alzheimer's Disease",0.535,"N/A",-0.243,0.5,1,"N/A","N/A"]
["Growth Hormone Signaling",0,"N/A",-0.577,-1.043,"N/A","N/A",-0.447]
["Aldosterone Signaling in Epithelial Cells",0.218,-1.342,0,-0.229,"N/A","N/A","N/A"]
["Lymphotoxin β Receptor Signaling",0,"N/A",-0.302,-0.277,"N/A","N/A",1]
["LPS/IL-1 Mediated Inhibition of RXR Function",0.426,"N/A",0,0.962,"N/A","N/A","N/A"]
["MicroRNA Biogenesis Signaling Pathway",0,"N/A",0,0,"N/A",1,"N/A"]
["p53 Signaling",-0.426,"N/A",0,0.209,"N/A","N/A",0]

{"sheet":"adj.p","index":1,"n_rows":175,"n_cols":8,"rows_kept":175,"flags":["formulas_cached_only"]}
["Canonical Pathways","Bulk_1G_Q_vs_1G","Bulk_uG_vs_1G","Bulk_uG_Q_vs_1G","Bulk_uG_Q_vs_uG","GLDS-420_host_counts_DEG","SC_uGvs1G_unstimulated","SC_uGvs1G_stimulated"]
["EIF2 Signaling",2.1647338593740497,0,4.87355150554733,7.945679716885504,0,27.031133775149193,15.169225096386475]
["Th1 Pathway",12.314322228360558,1.5140860049259615,13.211781405545533,11.385652801858093,0,11.593178581223839,6.674686784297389]
["Th2 Pathway",12.272663627341514,0.39023037206539196,15.372240420428243,10.410002910117283,0,8.817784989269597,3.2465778512814665]
["Neuroinflammation Signaling Pathway",7.465685345122856,0.3634821453411172,7.318386728420072,8.176158302636546,0,12.794284422603928,11.64711914866752]
["Pathogen Induced Cytokine Storm Signaling Pathway",9.54052437901818,4.0991995518563655,9.883666432742473,7.998262325052993,0,13.322152742031331,0]
["Phagosome Formation",12.223251429544744,0.4269603595174428,11.885344416397766,12.834855899850961,0.2391265083528759,1.6465645172177752,0.8761026261163192]
["Multiple Sclerosis Signaling Pathway",9.136138023821356,4.829146718299571,8.396440617582531,7.093680634122135,0,10.512369071842647,0]
["Hepatic Fibrosis Signaling Pathway",8.070255710260131,0.8632777764764844,8.63641721422903,6.962172391315841,0.7319022304489299,3.4169336803979444,7.227211932841358]
["PD-1, PD-L1 cancer immunotherapy pathway",5.6448379215347115,0.6654607865478052,4.682177036057585,3.9717509467961234,0.030224511386020086,14.68390045119694,5.597040038978241]
["Natural Killer Cell Signaling",4.343843890263122,0.09565867100760672,4.875560372903358,6.756767499208239,0.050227420954297254,10.590122510860976,6.674686784297389]
["IL-8 Signaling",8.993984099472385,0.2937071473207777,9.34929022138538,6.93310530329838,0,3.0483337258100067,4.299050433602108]
["RAC Signaling",9.278053686419634,0,8.529749810153577,10.879376904487557,0.036601425648924976,2.1240793725102263,2.0042213789644374]
["Coronavirus Pathogenesis Pathway",2.5095952842468745,0.23023404851974377,3.4421269961905008,3.441310679285862,0.21900158113887994,11.214809286281488,10.584604355473761]
["TEC Kinase Signaling",10.837782293047022,0,9.655064861845675,8.054456398441545,0,1.5037350361787507,1.0311951712750207]
["Macrophage Classical Activation Signaling Pathway",4.719907915147248,4.829146718299571,3.943848149569206,2.9537975752098133,0,13.648082672591194,0]
["Ephrin Receptor Signaling",8.766199422271011,0.1571930166722498,8.05425441304037,10.410002910117283,0.25078796214762283,1.7547928957808816,0.6695637528054222]
["Signaling by Rho Family GTPases",7.163989327248326,0.08289596079986247,7.059900792703296,8.035555251618993,0.05671483163057415,3.175117198126075,2.371446404855197]
["TREM1 Signaling",7.376802551008139,0.8385273842504971,6.1818667898660955,6.688250358958463,0,3.5646778329394233,3.295376454064028]
["CLEAR Signaling Pathway",9.628297558618394,0.10316812275396105,9.533972540655297,6.556857791210621,0.07063087317131496,0,1.4180757468592828]
["Interferon Signaling",2.7816739457865247,2.7295608872998915,2.2601940439246166,2.2097676363205405,1.1319175963084671,5.894956330252968,10.280915184732278]
["Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes",6.550947731939422,0.2580408525405856,8.265107824981618,7.7767553531465605,0,3.0703002410492517,1.070392508478134]
["Integrin Signaling",7.360151691283755,0.12758513789752537,8.05425441304037,8.037386589544063,0.07063087317131496,2.035490063563109,0.9005829609709615]
["FAK Signaling",7.48511702734514,0,8.63641721422903,8.037386589544063,0.0414808440922697,0.3819626918597803,0.5222115934676368]
["Cardiac Hypertrophy Signaling (Enhanced)",7.156049518781324,1.4911427193424331,6.207903522889961,5.116342411409003,0.2023731175809118,1.9749447699205454,1.7346616192295004]
["CTLA4 Signaling in Cytotoxic T Lymphocytes",7.511221680942355,0,7.02938114049604,5.562952726077686,0,3.4877054916130548,0.2845153471734494]
["Actin Cytoskeleton Signaling",7.315564160203952,0,6.593693536904412,7.319407330796624,0.07063087317131496,2.0763332653891173,0.3150786631362137]
["Production of Nitric Oxide and Reactive Oxygen Species in Macrophages",3.2724603968373245,1.0860837113618054,4.074062482992465,3.824347474230581,0,4.550618968119829,6.834378393499755]
["Dendritic Cell Maturation",6.3824467360138,0.18134593071475036,6.04839081156902,5.371592582521548,0,3.2382550252884776,2.3750931790063246]
["Colorectal Cancer Metastasis Signaling",7.156049518781324,0.45123721210789103,7.618489534046818,6.535165283623578,0,0.8443867304241929,0.8845333241370859]
["MSP-RON Signaling In Macrophages Pathway",3.6837819915678596,0.14751068298890588,5.925398463967099,6.35038404754798,0,3.6802723943234135,3.6315028182279026]
["Leukocyte Extravasation Signaling",6.534541999250851,0,6.208678585396521,5.302133181286576,0.2391265083528759,1.8374703613630272,2.3172099949860163]
["Regulation of Actin-based Motility by Rho",6.678642993961675,0.39023037206539196,6.412951416211751,5.628677973110266,0,1.9760140037384808,1.289065126143799]
["fMLP Signaling in Neutrophils",5.918984797183331,0,6.03748918502702,5.302133181286576,0,1.7547928957808816,2.713088489173921]
["Role of Hypercytokinemia/hyperchemokinemia in the Pathogenesis of Influenza",3.146866484173405,1.2012561873670722,3.0377957457203273,2.9903626982423686,0.18620717538588388,2.5904689453136114,8.466316512811996]
["Role of PKR in Interferon Induction and Antiviral Response",2.3728859837984624,0.5816988767888225,3.282916969949884,3.567960796473249,0,5.431463795985349,6.226090827195541]
["Pulmonary Healing Signaling Pathway",6.296435701017955,0.25423615466689564,6.293795661553713,5.110086440457999,0.26815321104166373,1.7738027083151864,1.3377786452899885]
["Osteoarthritis Pathway",5.0720469520596065,0.2937071473207777,5.010229908629128,4.534392870646179,0.2155891441868927,3.14489840795994,1.8060245855087176]
["STAT3 Pathway",4.785487197617409,0.8385273842504971,5.9505208628537165,4.550947187658769,1.2456622842157596,0.8525353606561968,1.5406152675209046]
["Tumor Microenvironment Pathway",2.80708398299804,0.8199282923602195,2.884422478929256,3.1108855419706427,0.07063087317131496,3.5719982047628225,6.4723719920182115]
["Role Of Osteoclasts In Rheumatoid Arthritis Signaling Pathway",4.058497021138198,0.6603137385506599,7.115919378057419,5.868215713506301,0,1.8374703613630272,0]
["CXCR4 Signaling",6.288959371907468,0.2704706439407056,7.034237486483147,4.447660998819131,0,0.627622146378788,0.8554409331028759]
["RHOGDI Signaling",6.025077599503707,0.2704706439407056,5.406614361207557,6.011416436502198,0.07063087317131496,1.1958992008508111,0.39454951117208226]
["Opioid Signaling Pathway",6.419465628596625,0.1075613826108056,6.567327965089611,4.559763155411404,0.0414808440922697,0.7975986240908818,0.5938228927524384]
["Chemokine Signaling",4.4619025228651505,0,5.551616162057442,4.2746856150515296,0,1.555507228220281,3.2278924833850553]
["CD28 Signaling in T Helper Cells",5.599454969526216,0,5.310244499693547,5.164103191034048,0,1.588033054961871,1.0406791947977718]
["T Cell Receptor Signaling",5.641882172359159,0,5.137671782683484,4.374196717682985,0,2.3880234107761473,1.1151638656915863]
["T Cell Exhaustion Signaling Pathway",4.937135748260072,0,4.834311069686103,4.5437235748400235,0,2.0959523694549484,2.2321977448239823]
["PI3K/AKT Signaling",5.019520671578966,0.16069567995554598,4.476705576834046,5.925597658106443,0.25078796214762283,1.7641703532854263,0.6849823555929625]
["Type I Diabetes Mellitus Signaling",3.9167677340681566,0,3.5882284497563854,2.703463824486623,0,4.112285769300604,3.4719625376927197]
["Immunogenic Cell Death Signaling Pathway",2.1647338593740497,0.1562032477216964,2.344919817900902,3.2788030927812732,0,9.516670979564312,0]
["Semaphorin Neuronal Repulsive Signaling Pathway",6.739750367849213,0,4.775222815198108,4.7791410124888545,0.24545151001529128,0.7318725737386486,0.18264772037894975]
["ERK/MAPK Signaling",4.695862505143155,0.057129313994866475,4.9503174344081815,4.985015103096651,0.16420996312294792,1.6211778072864067,0.8873599334374148]
["Pyroptosis Signaling Pathway",3.8332146415067974,1.1216260505372413,3.7013522852088703,4.026538921239031,0,2.415086887584159,2.1930887353075437]
["HIF1α Signaling",2.9340749875246774,0,3.2055675079652812,3.9134300941467126,0.24556736510020294,2.547463973460206,4.330962534440827]
["Sperm Motility",5.6675766317738425,0.2378039998732252,3.911836226153234,3.0459510062344646,1.382169357338808,2.3898720661972255,0.463898927410194]
["Aryl Hydrocarbon Receptor Signaling",2.8597748179591935,0.2937071473207777,3.7580774017831495,2.454586845961069,0.2391265083528759,3.4091979160280856,4.079654239974745]
["Glioma Invasiveness Signaling",3.8332146415067974,0.37017040207672497,5.86908826489353,4.497767548375972,0,0.34568561205015846,1.9457944708210275]
["CDC42 Signaling",5.277159129164289,0,4.6510950570436655,4.203645882527389,0,1.7641703532854263,0.8494657584283891]
["PKCθ Signaling in T Lymphocytes",4.608085655541151,0,5.411048843192733,4.9431504087647635,0,1.1024910614846102,0.3976725713188568]
["Ferroptosis Signaling Pathway",2.1486538178065464,0.30296396356349503,4.232283306563168,3.60015283664458,0.0414808440922697,2.8008975146048907,3.3238297454032635]
["ICOS-ICOSL Signaling in T Helper Cells",5.101908181481714,0,4.340183765590949,3.8670900445038314,0,1.648502550921667,0.6695637528054222]
["iNOS Signaling",1.8385107866504542,0.25423615466689564,2.1182039428838815,1.7346820151394373,0,5.028289607330709,4.472978156121981]
["Cholecystokinin/Gastrin-mediated Signaling",3.9827232088116475,0.3634821453411172,5.161861586731509,3.824347474230581,0,0.6436101950362847,1.2659406490986334]
["Sphingosine-1-phosphate Signaling",5.304639716473766,0.5272279679923277,4.700767516872681,3.412883462699732,0.16420996312294792,0.37058152113632553,0.5025931176743091]
["Synaptogenesis Signaling Pathway",4.607213153079475,0.2937071473207777,3.891672935333852,4.534392870646179,0.07063087317131496,0.6346433035499329,0.9265975936006369]
["Ephrin B Signaling",4.379015229828368,0,5.551616162057442,4.213612072507963,0.2391265083528759,0.35093018170315327,0.16908777869597888]
["Thrombin Signaling",5.631045784890192,0.4269603595174428,5.010959765914955,3.0989655711204374,0,0.23538263787853544,0.3623473209685256]
["Systemic Lupus Erythematosus In T Cell Signaling Pathway",4.360641982607099,0,4.081949381481311,3.690558424259834,0,0.7609381444158309,1.772423476891986]
["Pulmonary Fibrosis Idiopathic Signaling Pathway",3.8039139586595514,0.7240537612522443,4.54869879106965,3.541249579682201,0.38034621981531824,0.4120902986428377,1.1497506039734013]
["HMGB1 Signaling",1.774548849819834,1.6789688201130748,2.449099202006122,2.208115859796556,0,2.1647397139893316,3.920524050073041]
["Role Of Chondrocytes In Rheumatoid Arthritis Signaling Pathway",4.5629192977145125,0.08578970873925769,4.669967783659558,2.3891010530004273,0,2.066170332445092,0]
["ID1 Signaling Pathway",3.3674324540461105,0,4.14783679699619,2.703463824486623,0.25078796214762283,1.3725722118813295,1.7499139216851287]
["Reelin Signaling in Neurons",3.015593637575309,0.39023037206539196,3.1499823130733082,4.28484402199029,0.03596870521480032,1.2111146308968685,1.4952477052015543]
["Toll-like Receptor Signaling",3.642331121282194,0,3.500623315067239,2.4308745264492213,0,1.0568155476766699,2.5037851837617526]
["NF-κB Signaling",4.261015237641321,0,4.344233432145212,3.9121982223003418,0,0.3812948661438962,0]
["ILK Signaling",3.6224509933860083,0.08792882825135052,3.647890084057234,3.155621732555774,0.10382675038945377,0.4696110937443729,1.7499139216851287]
["G-Protein Coupled Receptor Signaling",3.4346469455063944,0.20275973323652055,4.437364672905056,4.2061126442256,0.2391265083528759,0.26957911800379497,0]
["Acute Phase Response Signaling",1.88162636560412,0.39023037206539196,3.214091064353803,3.2058971503330143,0.15982944052825646,1.5405748725175747,2.3875094952374827]
["LXR/RXR Activation",2.223066375479472,0.3590700985442401,1.9040235323605414,2.0826325052615604,0.25651453165291604,2.3898720661972255,3.5388608202653167]
["14-3-3-mediated Signaling",3.900605456540184,0,4.048229595204165,3.731128366002672,0.12318140965928094,0.1620285431078513,0.4758317510214509]
["Oxytocin Signaling Pathway",3.634581719302198,0.10626409279546631,4.232283306563168,3.1694531846157075,0.0414808440922697,0.3806973616901053,0.8324665807574747]
["Xenobiotic Metabolism AHR Signaling Pathway",2.1155637411276755,0.1610682597566678,2.603106771566411,1.090226565583834,0,3.9647004898732296,2.318964091235486]
["Oxytocin In Brain Signaling Pathway",3.747318354754768,0,3.7791641548412236,3.2788030927812732,0,0.7254617008558384,0.6949960427192221]
["NRF2-mediated Oxidative Stress Response",1.0977487318154275,0,1.9498643241788212,0.9910173716647017,0,4.793204295325115,3.294930522035515]
["Cardiac Hypertrophy Signaling",3.2724603968373245,0.3882893657720275,4.346093117970302,2.655962781926731,0,0.6446562551460294,0.6695637528054222]
["IL-15 Production",2.223066375479472,0.24026216223748365,1.9040235323605414,1.8587584468949219,1.181674240632489,3.588668909284796,0.8271689150981663]
["Differential Regulation of Cytokine Production in Macrophages and T Helper Cells by IL-17A and IL-17F",0.5975800511064785,0.0970786075228559,0.5995375147640539,0.5747753285811035,0,4.058039824475781,5.807495909551083]
["Gαq Signaling",3.9241572156803852,0.3591992058677403,3.214091064353803,2.9537975752098133,0,0.3812948661438962,0.8494657584283891]
["Prolactin Signaling",2.344165570189803,0.25423615466689564,3.48455719468613,2.208115859796556,0,0.8801056651731783,2.3348900686584195]
["Wound Healing Signaling Pathway",0.9384558347391462,0.563809560332361,1.1759502783824758,1.3888298182120322,0.2391265083528759,2.891189197026443,4.151908202662333]
["Differential Regulation of Cytokine Production in Intestinal Epithelial Cells by IL-17A and IL-17F",0.7940542166848032,0.0633627391327367,0.7997999225538106,0.7669937892134752,0,3.585946362993172,5.174807752150762]
["Calcium-induced T Lymphocyte Apoptosis",3.9166446350696713,0,3.267206847788515,2.814047581095548,0,0.8605297500815468,0.3202427551847838]
["Role of MAPK Signaling in Inhibiting the Pathogenesis of Influenza",1.1875081778730021,0.08792882825135052,1.3377379697115113,0.7669937892134752,0,2.840808351789466,4.942954065017099]
["Apelin Endothelial Signaling Pathway",3.6448179765815962,0,3.7580774017831495,1.7345350878202315,0,0.5084451631171613,1.4730446378457371]
["Inhibition of Matrix Metalloproteases",2.7931472262576444,0.8971494246434724,3.2090893355054484,2.694463257596066,0.25078796214762283,0.23974776982216722,0.7693727762838474]
["Breast Cancer Regulation by Stathmin1",3.2522301564675775,0.13384705577629627,3.919933292690154,2.6704599350382012,0.24556736510020294,0,0.6125011058366225]
["CCR5 Signaling in Macrophages",3.8332146415067974,0,3.829297416860554,2.3364684512475753,0,0.20801380230101246,0.5110559463514434]
["p38 MAPK Signaling",1.3404895503139862,0,2.3059728432612157,0.7986048238971344,0.0642286148620854,2.4373795445555415,3.6149797937876986]
["Endothelin-1 Signaling",3.585830352088965,0,3.144274953159833,2.666427595117665,0.2391265083528759,0.32160853480241414,0.4606679318608788]
["Necroptosis Signaling Pathway",1.553088469930113,0,1.6259553558878763,0.7493373446485869,0,2.3574767445504556,4.1206846610545975]
["Role of NFAT in Cardiac Hypertrophy",3.8332146415067974,0.10418789187081749,3.8532319718554,1.788282221882007,0,0.5969573961164696,0]
["Growth Hormone Signaling",2.905938225688396,0.11064209883500785,3.1801290581442503,1.553916320126321,0,0.3558632608058867,1.9853306500922059]
["IL-17 Signaling",0.7000259832563458,0.3882893657720275,0.868481936141742,0.545472440374497,0,3.4169336803979444,4.1226085004079165]
["PTEN Signaling",3.441059885755074,0,2.4970824523805177,2.722364212009732,1.1474470261272651,0,0.18424871151583683]
["Apelin Adipocyte Signaling Pathway",2.030213694339257,0,2.1893716212779832,0.8959926113434508,0.04943740915684358,1.867825606993557,2.9166907958846844]
["Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes",3.3418728058225007,0,3.3443690732923894,2.890164048064137,0,0.36637423828943616,0]
["Antioxidant Action of Vitamin C",2.586233899708571,0.2858320048250626,1.7607070762585129,1.720970798389209,0.06773152794431177,2.606997964660867,0.907256335694692]
["BAG2 Signaling Pathway",0,0,0.4874303273842041,0.19636710966074206,0.2004503214775101,5.859966729306787,3.107561245632624]
["Erythropoietin Signaling Pathway",0.9606481013486159,0.6070086681472484,1.4241654622381463,1.553916320126321,0.07063087317131496,2.035490063563109,3.107561245632624]
["Role of IL-17F in Allergic Inflammatory Airway Diseases",0.576703314535765,0.4269603595174428,0.980132903230938,0.5483278855834577,0,1.648502550921667,5.571417197931795]
["IL-23 Signaling Pathway",0.8236813578138023,0.2597565653760734,1.04420915389006,1.2300598399245632,0,1.671951754294832,4.522997226512398]
["HER-2 Signaling in Breast Cancer",1.250038512360362,0,1.5589687066900337,1.5253918385895682,0,3.2669908625746364,1.904681606036207]
["CREB Signaling in Neurons",2.5553696617767794,0.32521451538926793,3.3019820076286863,2.530380639159003,0.7048104470487166,0,0]
["IL-13 Signaling Pathway",1.738723023733256,0.06753005742254155,1.8649975037217927,0.6699465542406915,0,1.9731570612817697,3.029663525819036]
["NAD Signaling Pathway",2.399145723666697,0.8826496427615086,1.8649975037217927,2.0311450948427856,0,0.7266425710298331,1.372089937632421]
["Regulation Of The Epithelial Mesenchymal Transition By Growth Factors Pathway",2.1126599346859987,0,1.9828392303565874,1.9542770980857374,0.2391265083528759,0.5037757391225229,2.322786370672475]
["Thrombopoietin Signaling",1.9962788198812635,0,2.5810352322003935,2.544326188490454,0,0.39640487764865534,1.5088431134614373]
["IL-6 Signaling",0.49859284532795367,0,1.0980850797670747,1.0410229558767985,0,1.3315601040864304,4.836172191342083]
["GM-CSF Signaling",1.246321241733979,0.11508802919596026,1.6696601925070687,1.6211302354645745,0,1.1760210043867583,2.7337360595319447]
["Unfolded protein response",1.4439808973662176,0,1.1860583351954117,1.7851002211272589,0.25078796214762283,3.175117198126075,0.3682676318683542]
["JAK/STAT Signaling",1.0477928779292531,0.18944649024786767,2.119108383267662,1.8222916069223047,0,0.5956649074413877,2.3937890393948402]
["GP6 Signaling Pathway",2.468979359904465,0,2.0995648887658556,1.8543199737405327,0.25651453165291604,0.5952528011109617,0.8012613756622773]
["Estrogen Receptor Signaling",1.705932754202253,0,1.638570258810714,1.031151588167929,0,2.3784480484602155,1.2884173399061931]
["LPS/IL-1 Mediated Inhibition of RXR Function",2.226915751162397,0.1610682597566678,2.410713271612217,1.3324300780874387,0.1504551678011235,0.4696110937443729,1.2884173399061931]
["NUR77 Signaling in T Lymphocytes",2.5553696617767794,0,2.040178399293103,1.5080271501089626,0,0.8525353606561968,1.0603763570950906]
["Death Receptor Signaling",1.5478582639431535,0.12758513789752537,1.2772499028545814,0.9006421929085572,0,1.2830414709457383,2.7899478944888725]
["Oxidative Phosphorylation",0,0,0,0,0,7.326363331815811,0.5548195484502512]
["Sumoylation Pathway",1.3845494822402205,0.10626409279546631,1.514944255255616,1.2814818462600814,0,0.22634499973836805,3.3175994948435497]
["PEDF Signaling",1.1447708111745856,0,1.9854599786916978,1.6911240734289916,0,0.5786488662389684,2.371446404855197]
["RHOA Signaling",1.536534842361769,0.12849806323152005,1.8489494823913863,1.5978585068414015,0,1.8374703613630272,0.8194367247983705]
["Huntington's Disease Signaling",1.373575362282352,0,2.558922447919129,0.6755642108375994,0,2.066170332445092,1.091697565261105]
["Autophagy",2.3013023709258196,0,1.9828392303565874,1.4780071290552117,0.036429514366216956,0.2531573748865891,1.605457384683136]
["Sirtuin Signaling Pathway",0.5704340335872522,0,0,0.5747753285811035,0,4.257911590961471,2.13681373078987]
["p53 Signaling",1.6496243572633256,0,1.5778243035866635,1.7551564854480348,0.11371080475853743,0,2.0951689943004856]
["Tumoricidal Function of Hepatic Natural Killer Cells",0.7161567203993988,0,1.0241676909173039,0.9771829996230003,0,1.65132676637656,2.7998237954037757]
["Role of IL-17A in Psoriasis",0.34797724034516564,0.3957829761689495,0.34572251527914666,0.14381226462970687,0,2.1759220707011275,3.6315028182279026]
["PPARα/RXRα Activation",1.1911212729457281,0,1.6740323632163339,1.3434689228845689,0,1.8194872159170563,1.0078732575722726]
["OX40 Signaling Pathway",1.715380276402126,0,1.6262900791216073,1.413635692840612,0,1.2583260492719859,0.9598425443846814]
["Inhibition of Angiogenesis by TSP1",0.8294193663466051,0.36210196616335066,1.3750789162921957,0.5733768873272517,0.25078796214762283,2.035490063563109,1.4952477052015543]
["Aldosterone Signaling in Epithelial Cells",0.7347776890864978,0.25423615466689564,1.0547927475967953,0.49151602349633355,0,3.2353394181745925,0.8873599334374148]
["IL-7 Signaling Pathway",1.7053604284876973,0.20692712060165536,1.1925674536173412,0.6546080853314078,0,1.0568155476766699,1.837894071310398]
["Endocannabinoid Cancer Inhibition Pathway",1.9722732095872566,0,2.056875698599389,1.4569294433768323,0.25078796214762283,0,0.6695637528054222]
["Insulin Secretion Signaling Pathway",1.3178729476108917,0.3590700985442401,1.3192569415326658,0.7937272971280993,0,1.4625807846800363,1.1530971262177705]
["PPAR Signaling",0.4930732520948702,0,0.8395710265420511,1.2814818462600814,0,1.1463094092052901,2.5294817516769603]
["Telomerase Signaling",1.1617194108745494,0,1.115885999193598,0.7797316171933197,0,1.612713283956763,1.4034406216395667]
["CDX Gastrointestinal Cancer Signaling Pathway",1.1104415585911493,0.9662313842292487,1.1579554197709991,1.0025569296030923,0,1.7547928957808816,0]
["Cytotoxic T Lymphocyte-mediated Apoptosis of Target Cells",1.6276958461683149,0,1.450688746073393,1.1497746505016047,0,0.6105544625689339,0.9436163326140415]
["cAMP-mediated signaling",1.9717733314421666,0.2178080434590319,1.9856921697738015,1.1118513413803555,0.25078796214762283,0.2133091594110766,0]
["Protein Kinase A Signaling",2.1435546537672354,0,1.6996480914397722,0.8460028519084196,0.2391265083528759,0.6578102210740395,0]
["Factors Promoting Cardiogenesis in Vertebrates",2.070806042500179,0.6230804902193925,1.405746258512818,1.0663023255043096,0.0642286148620854,0.2622840879146496,0]
["Corticotropin Releasing Hormone Signaling",1.218648298060064,0.2243676061389668,2.2001713737624624,0.9835058705020089,0.0669933804646856,0.26421676178148995,0.3848699285387333]
["FAT10 Cancer Signaling Pathway",1.0519960192685176,0,1.0343981142321474,0.7836826306468103,0,1.5783574364961366,0.6376998185718588]
["Activation of IRF by Cytosolic Pattern Recognition Receptors",0.32443078572639544,0.29327280004116385,0.8691473901799806,1.012809840988848,0.030224511386020086,0.3817477077960431,2.13681373078987]
["Nitric Oxide Signaling in the Cardiovascular System",1.0176607653725986,0.14397407912694166,1.6397128699706334,0.6789660815717042,0.0642286148620854,0.6381826188158695,0.8494657584283891]
["Senescence Pathway",1.1809319772367735,0,1.394674980058517,1.041592261140328,0,0,1.3245744854310726]
["Induction of Apoptosis by HIV1",0.2367187301453531,0,0.6888895172626043,0.3867468347836378,0,2.4799000559887863,0.9401281235964688]
["HOTAIR Regulatory Pathway",0.537949683605846,0.29327280004116385,0.3468878871988232,0.9015661711275711,0.2391265083528759,0.6490948897245474,1.703625364185054]
["Dopamine-DARPP32 Feedback in cAMP Signaling",1.5042762327638255,0.742307975185689,1.1392596015342369,1.0865349288320993,0.16420996312294792,0,0]
["eNOS Signaling",0.592549911763131,0,0.7684979113523338,0.5421369846735642,0.25078796214762283,1.441941259400308,0.9188004018013752]
["Synaptic Long Term Depression",1.3726479551477584,0.1610682597566678,1.2772499028545814,1.0025569296030923,0.05671483163057415,0.3070007492665128,0.2553519354903218]
["Adrenomedullin signaling pathway",1.484584675102134,0,1.1267821560725089,0.9771829996230003,0,0,0.6849823555929625]
["Inhibition of ARE-Mediated mRNA Degradation Pathway",0,0.10626409279546631,0.3118692153556798,0.22111767525364528,0,1.7818871219749093,1.725090209673456]
["Granzyme A Signaling",0,0,0,0,0,3.606539532712204,0.4869798350248576]
["CD40 Signaling",0.6267285296914472,0,0.9648348607410336,0.9189509529148265,0.030224511386020086,0,1.446594205550331]
["Neuroprotective Role of THOP1 in Alzheimer's Disease",0,0.054566701260816176,0,0,0.2625883158017938,1.8788817361312802,1.7448161603941488]
["Systemic Lupus Erythematosus In B Cell Signaling Pathway",0,0.08792882825135052,0,0,0,0.5455129441673593,3.261176931447504]
["EGF Signaling",0.5596456771413474,0,0.92409576289651,0.3867468347836378,0,0.1683258237216398,1.6951614236278731]
["Retinoic acid Mediated Apoptosis Signaling",0.5704340335872522,0.32025724027060104,0.32094654430437636,0.3974876880991457,0,0.4207025834819166,1.5758152413451674]
["Role of NFAT in Regulation of the Immune Response",0.342931646551806,0,0,0,0,2.2412993783983546,0.6248967455185537]
["Lymphotoxin β Receptor Signaling",0,0,0.4385279194960779,0.568253363715622,0,0.4638356290650209,1.6951614236278731]
["BEX2 Signaling Pathway",0.2727528418349443,0,0.535057493683539,0.5204328158113439,0,0,1.7799037078222513]
["PI3K Signaling in B Lymphocytes",0,0,0,0,0,0.7739658826588472,1.9396435261035216]
["MicroRNA Biogenesis Signaling Pathway",0,0,0,0,0,1.901734521504569,0]
["Kinetochore Metaphase Signaling Pathway",0,0,0,0,1.5031176982682997,0,0]